KCa3.1 is expressed on a number of primary tumor cells, including glioblastoma and melanoma; blocking those channels reduces the invasiveness and proliferation of those tumors and induces their apoptosis [46]–[48]. The gene discussed is KCNN4; the disease is neoplasm.